Robin Wright
Fortuna: 31 849 $ al 30/06/2026
Fortuna: 31 849 $ al 30/06/2026
Robin Wright is Chairman at Barinthus Biotherapeutics (UK) Ltd. and Barinthus Biotherapeutics Plc, Director at KDev Investments AB, and Fellow at The Institute of Chartered Accountants in England & Wales.
Former roles include Chief Financial Officer at Pharming Group NV from 2015 to 2020, CFO & Head-Business Development at Orexo AB from 2008 to 2011, and Chief Financial Officer at Karolinska Development AB (Private Equity) from 2011 to 2014.
Education includes an undergraduate degree from the University of Oxford.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 05/06/2026 | 48.256 ( 0,12 % ) | 31 849 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| BARINTHUS BIOTHERAPEUTICS PLC | Presidente | 01/10/2018 |
KDev Investments AB
KDev Investments AB BiotechnologyHealth Technology Engages in research, sales, and development in the fields of medicine and owns and manages investments | Director/Miembro de la Junta | - |
Vaccitech (UK) Ltd.
Vaccitech (UK) Ltd. BiotechnologyHealth Technology Engages in research and experimental development on biotechnology | Presidente | - |
Institute of Chartered Accountants in England & Wales
Institute of Chartered Accountants in England & Wales Miscellaneous Commercial ServicesCommercial Services Offers accountancy qualifications and world class business resources | Corporate Officer/Principal | - |
| Empresas | Cargo | Fin |
|---|---|---|
| PHARMING GROUP N.V. | Director Financiero/CFO | 20/05/2020 |
Karolinska Development AB (Private Equity)
Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development seeks investment in companies located in the Nordic region, primarily in Swedish. The firm targets companies operating in the fields of health technology, health services, medical devices, technology services, life science. It provides financing for early stage capital requirements. It takes a seat on the board of directors. | Director Financiero/CFO | 28/02/2014 |
| OREXO AB | Director Financiero/CFO | 01/06/2011 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 8 |
|---|---|
University of Oxford
University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Institute of Chartered Accountants in England & Wales
Institute of Chartered Accountants in England & Wales Miscellaneous Commercial ServicesCommercial Services Offers accountancy qualifications and world class business resources | Commercial Services |
Pharming Group NV
Pharming Group NV Pharmaceuticals: MajorHealth Technology Develops and commercializes protein replacement therapies and precision medicines | Health Technology |
Orexo AB
Orexo AB Pharmaceuticals: MajorHealth Technology Manufactures and commercializes pharmaceutical products | Health Technology |
Karolinska Development AB (Private Equity)
Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development seeks investment in companies located in the Nordic region, primarily in Swedish. The firm targets companies operating in the fields of health technology, health services, medical devices, technology services, life science. It provides financing for early stage capital requirements. It takes a seat on the board of directors. | Finance |
KDev Investments AB
KDev Investments AB BiotechnologyHealth Technology Engages in research, sales, and development in the fields of medicine and owns and manages investments | Health Technology |
Vaccitech (UK) Ltd.
Vaccitech (UK) Ltd. BiotechnologyHealth Technology Engages in research and experimental development on biotechnology | Health Technology |
Vaccitech Plc
Vaccitech Plc Pharmaceuticals: MajorHealth Technology Discovers and develops immunotherapeutic products and vaccines for the treatment and prevention of infectious and cancer diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.